Adalimumab and secukinumab are the only FDA-approved biologic drugs to treat hidradenitis suppurativa, limiting options for ...
Advocates say it is discrimination and are arguing for “insurance fairness” on the grounds that people who have joints ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback